{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:31:48Z","timestamp":1788571908847,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CP17\/00188"],"award-info":[{"award-number":["CP17\/00188"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI19\/01514)"],"award-info":[{"award-number":["PI19\/01514)"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCLA Breast Cancer Epigenetics Research Program"},{"name":"CTSI UCLA","award":["UL1TR000124UCLA"],"award-info":[{"award-number":["UL1TR000124UCLA"]}]},{"name":"Fashion Footwear of New York"},{"name":"AECC Foundation"},{"name":"Associates for Breast and Prostate Cancer Studies"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1245\/s10434-022-11684-0","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T23:03:32Z","timestamp":1649545412000},"page":"4716-4724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease"],"prefix":"10.1245","volume":"29","author":[{"given":"Miquel","family":"Ensenyat-Mendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"R\u00fcnger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier I. J.","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Weidhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego M.","family":"Marzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-292X","authenticated-orcid":false,"given":"Maggie L.","family":"DiNome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"issue":"7458","key":"11684_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0140-6736(66)92590-6","volume":"2","author":"D Brinkley","year":"1966","unstructured":"Brinkley D, Haybittle SL. Treatment of stage-II carcinoma of the female breast. Lancet. 1966;2(7458):291\u20135.","journal-title":"Lancet."},{"issue":"4","key":"11684_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/02841860801989753","volume":"47","author":"H Johansen","year":"2008","unstructured":"Johansen H, Kaae S, Jensen MB, Mouridsen HT. Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study. Acta Oncol. 2008;47(4):633\u20138.","journal-title":"Acta Oncol."},{"issue":"8","key":"11684_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567\u201375.","journal-title":"N Engl J Med."},{"issue":"10","key":"11684_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23\u201301): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385\u201393.","journal-title":"Lancet Oncol."},{"issue":"12","key":"11684_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol."},{"issue":"6","key":"11684_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA."},{"issue":"3","key":"11684_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364.","journal-title":"J Clin Oncol."},{"issue":"7","key":"11684_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol."},{"issue":"14","key":"11684_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361.","journal-title":"JAMA."},{"key":"11684_CR10","doi-asserted-by":"crossref","unstructured":"Boughey JC, McCall LM, Ballman KV, et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Ann Surg. 2014;260(4):608-14; discussion 14-6.","DOI":"10.1097\/SLA.0000000000000924"},{"issue":"36","key":"11684_CR11","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","volume":"23","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Hortobagyi GN, Rouzier R, et al. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol. 2005;23(36):9304\u201311.","journal-title":"J Clin Oncol."},{"issue":"5","key":"11684_CR12","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1245\/s10434-020-09228-5","volume":"28","author":"S Angarita","year":"2021","unstructured":"Angarita S, Ye L, Runger D, et al. Assessing the burden of nodal disease for breast cancer patients with clinically positive nodes: hope for more limited axillary surgery. Ann Surg Oncol. 2021;28(5):2609\u201318.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"11684_CR13","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1245\/s10434-021-09943-7","volume":"28","author":"A Crown","year":"2021","unstructured":"Crown A, Sevilimedu V, Morrow M. Palpable adenopathy does not indicate high-volume axillary nodal disease in hormone receptor-positive breast cancer. Ann Surg Oncol. 2021;28(11):6060\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"11684_CR14","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1245\/aso.2003.03.015","volume":"10","author":"KJ Van Zee","year":"2003","unstructured":"Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):1140\u201351. https:\/\/doi.org\/10.1245\/aso.2003.03.015.","journal-title":"Ann Surg Oncol."},{"key":"11684_CR15","doi-asserted-by":"publisher","unstructured":"Zhu L, Jin L, Li S, et al. Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis [published erratum appears in: Breast Cancer Res Treat. 2013;139(1):295-300]. Breast Cancer Res Treat. 2013;137(3):783-95. doi: https:\/\/doi.org\/10.1007\/s10549-012-2360-6.","DOI":"10.1007\/s10549-012-2360-6"},{"issue":"28","key":"11684_CR16","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.1703577114","volume":"114","author":"X Hao","year":"2017","unstructured":"Hao X, Luo H, Krawczyk M, et al. DNA methylation markers for diagnosis and prognosis of common cancers. Proc Natl Acad Sci USA. 2017;114(28):7414\u20139.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"2","key":"11684_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41596-019-0251-6","volume":"15","author":"ME Maros","year":"2020","unstructured":"Maros ME, Capper D, Jones DTW, et al. Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data. Nat Protoc. 2020;15(2):479\u2013512.","journal-title":"Nat Protoc."},{"issue":"1","key":"11684_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13040-021-00273-8","volume":"14","author":"M Ensenyat-Mendez","year":"2021","unstructured":"Ensenyat-Mendez M, Iniguez-Munoz S, Sese B, Marzese DM. iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes. BioData Min. 2021;14(1):42.","journal-title":"BioData Min."},{"issue":"10","key":"11684_CR19","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","volume":"17","author":"S Moran","year":"2016","unstructured":"Moran S, Martinez-Cardus A, Sayols S, et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(10):1386\u201395.","journal-title":"Lancet Oncol."},{"issue":"1","key":"11684_CR20","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1038\/s41467-018-06715-y","volume":"9","author":"JIJ Orozco","year":"2018","unstructured":"Orozco JIJ, Knijnenburg TA, Manughian-Peter AO, et al. Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun. 2018;9(1):4627.","journal-title":"Nat Commun."},{"issue":"2","key":"11684_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3892\/or.2020.7886","volume":"45","author":"Q An","year":"2021","unstructured":"An Q, Liu T, Wang MY, et al. KRT7 promotes epithelialmesenchymal transition in ovarian cancer via the TGFbeta\/Smad2\/3 signaling pathway. Oncol Rep. 2021;45(2):481\u201392.","journal-title":"Oncol Rep."},{"issue":"37","key":"11684_CR22","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1038\/onc.2016.25","volume":"35","author":"B Huang","year":"2016","unstructured":"Huang B, Song JH, Cheng Y, et al. Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression. Oncogene. 2016;35(37):4927\u201336.","journal-title":"Oncogene."},{"issue":"2","key":"11684_CR23","first-page":"321","volume":"36","author":"M Sano","year":"2010","unstructured":"Sano M, Aoyagi K, Takahashi H, et al. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int J Oncol. 2010;36(2):321\u201330.","journal-title":"Int J Oncol."},{"issue":"12","key":"11684_CR24","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1245\/s10434-020-08888-7","volume":"27","author":"G Montagna","year":"2020","unstructured":"Montagna G, Sevilimedu V, Fornier M, Jhaveri K, Morrow M, Pilewskie ML. How effective is neoadjuvant endocrine therapy (NET) in downstaging the axilla and achieving breast-conserving surgery? Ann Surg Oncol. 2020;27(12):4702\u201310.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"11684_CR25","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1245\/s10434-020-08905-9","volume":"27","author":"A Stafford","year":"2020","unstructured":"Stafford A, Williams A, Edmiston K, et al. Axillary response in patients undergoing neoadjuvant endocrine treatment for node-positive breast cancer: systematic literature review and NCDB analysis. Ann Surg Oncol. 2020;27(12):4669\u201377.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"11684_CR26","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/j.clbc.2020.11.008","volume":"21","author":"T Murata","year":"2021","unstructured":"Murata T, Watase C, Shiino S, et al. Development and validation of a preoperative scoring system to distinguish between nonadvanced and advanced axillary lymph node metastasis in patients with early-stage breast cancer. Clin Breast Cancer. 2021;21(4):e302\u201311.","journal-title":"Clin Breast Cancer."},{"issue":"1","key":"11684_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1148\/radiol.2019190372","volume":"294","author":"LQ Zhou","year":"2020","unstructured":"Zhou LQ, Wu XL, Huang SY, et al. Lymph node metastasis prediction from primary breast cancer US images using deep learning. Radiology. 2020;294(1):19\u201328.","journal-title":"Radiology."},{"issue":"8","key":"11684_CR28","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.21037\/qims-20-1201","volume":"11","author":"T Jiang","year":"2021","unstructured":"Jiang T, Su W, Zhao Y, Li Q, Huang P. Non-invasive prediction of lymph node status for patients with early-stage invasive breast cancer based on a morphological feature from ultrasound images. Quant Imaging Med Surg. 2021;11(8):3399\u2013407. https:\/\/doi.org\/10.21037\/qims-20-1201.","journal-title":"Quant Imaging Med Surg."},{"key":"11684_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.754843","volume":"11","author":"C Wang","year":"2021","unstructured":"Wang C, Chen X, Luo H, et al. Development and internal validation of a preoperative prediction model for sentinel lymph node status in breast cancer: combining radiomics signature and clinical factors. Front Oncol. 2021;11:754843. https:\/\/doi.org\/10.3389\/fonc.2021.754843.","journal-title":"Front Oncol."},{"issue":"42","key":"11684_CR30","doi-asserted-by":"publisher","first-page":"e12862","DOI":"10.1097\/MD.0000000000012862","volume":"97","author":"JH Lee","year":"2018","unstructured":"Lee JH, Jeong H, Choi JW, Oh HE, Kim YS. Liquid biopsy prediction of axillary lymph node metastasis, cancer recurrence, and patient survival in breast cancer: a meta-analysis. Medicine. 2018;97(42):e12862.","journal-title":"Medicine."},{"issue":"4","key":"11684_CR31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1245\/s10434-010-1393-5","volume":"18","author":"K Gyobu","year":"2011","unstructured":"Gyobu K, Yamashita S, Matsuda Y, et al. Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18(4):1185\u201394.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"11684_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/15592294.2015.1075689","volume":"10","author":"LJ Melchers","year":"2015","unstructured":"Melchers LJ, Clausen MJ, Mastik MF, et al. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma. Epigenetics. 2015;10(9):850\u201360.","journal-title":"Epigenetics."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11684-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:07:26Z","timestamp":1656619646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["11684"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11684-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Miquel Ensenyat-Mendez, Dennis R\u00fcnger, Javier I.J. Orozco, Julie Le, Jennifer L. Baker, Joanne Weidhaas, Diego M. Marzese, and Maggie L. DiNome have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}